Blab Entertainment
Obsession Breaks $250 Million Domestic Record, Outpacing 14 Marvel Studios Films
A modest horror flick has shattered box‑office expectations, crossing the $250 million mark in the United States in just nine weeks after its theatrical debut. Obsession, a low‑budget film that cost $750,000 to make and was directed by Curry Barker, has eclipsed the domestic earnings of 14 Marvel Studios releases that appeared over the past decade.
The independent picture was snapped up by Focus Features for $15 million at the 2025 Toronto International Film Festival, according to a report in The Hollywood Reporter. That purchase price was a tiny fraction of the film’s eventual haul, which now sits at $256.78 million domestically. Worldwide, Obsession has pulled in $430.13 million, ranking it seventh on the annual global box‑office list.
Its domestic triumph places Obsession ahead of a string of MCU titles, including The Incredible Hulk ($134.8 million), Thor ($181 million), Captain America: The First Avenger ($176.7 million), Thor: The Dark World ($206.4 million), Ant‑Man ($180.2 million), Doctor Strange ($232.6 million), Ant‑Man and the Wasp ($216.6 million), Black Widow ($183.7 million), Shang‑Chi and the Legend of the Ten Rings ($224.5 million), Eternals ($164.9 million), Ant‑Man and the Wasp: Quantumania ($214.5 million), The Marvels ($84.5 million), Captain America: Brave New World ($200.5 million), and Thunderbolts ($190.3 million). In the global arena, the horror film has outpaced seven MCU movies: The Incredible Hulk ($265.6 million), Captain America: The First Avenger ($370.6 million), Black Widow ($379.8 million), Eternals ($402.1 million), The Marvels ($206.1 million), Captain America: Brave New World ($415.1 million), and Thunderbolts ($382.4 million).
A key factor in the film’s sustained performance is its impressive box‑office legs. By its fifth weekend, Obsession had already surpassed Avengers: Endgame, the Infinity Saga’s record‑setter, and it has continued to lead in subsequent weeks. The momentum has been fueled by strong word‑of‑mouth and a viral marketing push that kept the horror title in circulation longer than many mainstream releases.
Although the movie has secured a digital release, theaters remain its primary revenue engine. Its current global total of $430.13 million sits just shy of the $432.2 million earned by Shang‑Chi and still trails Thor ($449.3 million) and Ant‑Man 3 ($476 million). The film’s ongoing theatrical run suggests it could soon overtake Shang‑Chi if the trend continues.
The achievement of a low‑budget horror film reaching a quarter‑billion dollars domestically is a rare event. Independent horror titles typically generate far less, so Obsession’s performance demonstrates that modest production costs can translate into significant box‑office returns when paired with effective distribution and audience engagement.
The success story may influence future strategies for independent studios. Focus Features’ $15 million acquisition at TIFF and its subsequent rollout illustrate a model that could be replicated for other low‑budget projects. The film also underscores the profitability of horror in today’s cinematic landscape.
For now, Obsession remains a leading performer of the year, with its domestic and global earnings still on the rise. Distributors, exhibitors, and independent filmmakers will watch its trajectory closely, hoping to glean lessons that could help replicate its remarkable success.
The independent picture was snapped up by Focus Features for $15 million at the 2025 Toronto International Film Festival, according to a report in The Hollywood Reporter. That purchase price was a tiny fraction of the film’s eventual haul, which now sits at $256.78 million domestically. Worldwide, Obsession has pulled in $430.13 million, ranking it seventh on the annual global box‑office list.
Its domestic triumph places Obsession ahead of a string of MCU titles, including The Incredible Hulk ($134.8 million), Thor ($181 million), Captain America: The First Avenger ($176.7 million), Thor: The Dark World ($206.4 million), Ant‑Man ($180.2 million), Doctor Strange ($232.6 million), Ant‑Man and the Wasp ($216.6 million), Black Widow ($183.7 million), Shang‑Chi and the Legend of the Ten Rings ($224.5 million), Eternals ($164.9 million), Ant‑Man and the Wasp: Quantumania ($214.5 million), The Marvels ($84.5 million), Captain America: Brave New World ($200.5 million), and Thunderbolts ($190.3 million). In the global arena, the horror film has outpaced seven MCU movies: The Incredible Hulk ($265.6 million), Captain America: The First Avenger ($370.6 million), Black Widow ($379.8 million), Eternals ($402.1 million), The Marvels ($206.1 million), Captain America: Brave New World ($415.1 million), and Thunderbolts ($382.4 million).
A key factor in the film’s sustained performance is its impressive box‑office legs. By its fifth weekend, Obsession had already surpassed Avengers: Endgame, the Infinity Saga’s record‑setter, and it has continued to lead in subsequent weeks. The momentum has been fueled by strong word‑of‑mouth and a viral marketing push that kept the horror title in circulation longer than many mainstream releases.
Although the movie has secured a digital release, theaters remain its primary revenue engine. Its current global total of $430.13 million sits just shy of the $432.2 million earned by Shang‑Chi and still trails Thor ($449.3 million) and Ant‑Man 3 ($476 million). The film’s ongoing theatrical run suggests it could soon overtake Shang‑Chi if the trend continues.
The achievement of a low‑budget horror film reaching a quarter‑billion dollars domestically is a rare event. Independent horror titles typically generate far less, so Obsession’s performance demonstrates that modest production costs can translate into significant box‑office returns when paired with effective distribution and audience engagement.
The success story may influence future strategies for independent studios. Focus Features’ $15 million acquisition at TIFF and its subsequent rollout illustrate a model that could be replicated for other low‑budget projects. The film also underscores the profitability of horror in today’s cinematic landscape.
For now, Obsession remains a leading performer of the year, with its domestic and global earnings still on the rise. Distributors, exhibitors, and independent filmmakers will watch its trajectory closely, hoping to glean lessons that could help replicate its remarkable success.
